Literature DB >> 15689680

Approaches to endoscopic ampullectomy.

Robert F Wong1, James A DiSario.   

Abstract

PURPOSE OF REVIEW: Ampullary tumors, usually adenomas, are often encountered during endoscopic evaluation, especially in patients with familial adenomatous polyposis (FAP). Because of the risk of progression to adenocarcinoma, ampullary adenomas should be treated. Endoscopic therapy is an appropriate option and recent experience highlights the effectiveness and safety of this approach. RECENT
FINDINGS: Several authors have published experiences with endoscopic ampullectomy. In the current era, endoscopic ampullectomy is performed like a snare polypectomy using a side-viewing duodenoscope. Tumors are removed either en bloc or in a piecemeal fashion with retrieval of all tissue. Because of the potential for incidental carcinoma when all tissue is removed, complete retrieval is essential. Although initially used as primary therapy, thermal ablation, such as ionized argon coagulation (IAC), is now commonly used as adjunctive therapy. Prophylactic pancreatic or biliary stent placement is also performed to minimize risks of pancreatitis, jaundice, cholangitis, and stenosis. Endoscopic therapy is effective in removing more than 80% of adenomas, though several sessions may be necessary. Complications are reported in 20% of patients from most series and include acute pancreatitis, bleeding, perforation, orifice stenosis, and, rarely death. Recurrence of the adenoma can occur, especially in FAP patients, and warrants periodic surveillance.
SUMMARY: Endoscopic ampullectomy appears to be an effective method for treating ampullary tumors. However, complications are significant and only well-trained and experienced endoscopists should perform ampullectomy. Future research should focus on multicenter, randomized clinical trials to determine the best therapeutic approach for patients with ampullary tumors and to determine methods to decrease complication rates associated with endoscopic therapy.

Entities:  

Year:  2004        PMID: 15689680     DOI: 10.1097/00001574-200409000-00008

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  7 in total

1.  Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome.

Authors:  Tianle Ma; Eun Jeong Jang; Lawrence R Zukerberg; Robert Odze; Manish K Gala; Peter B Kelsey; David G Forcione; William R Brugge; Brenna W Casey; Sapna Syngal; Daniel C Chung
Journal:  Surg Endosc       Date:  2014-02-25       Impact factor: 4.584

Review 2.  Endoscopic papillectomy: indications, techniques, and results.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

3.  Endoscopic snare papillectomy with biliary and pancreatic stent placement for tumors of the major duodenal papilla.

Authors:  Takuji Yamao; Hajime Isomoto; Shigeru Kohno; Yohei Mizuta; Masaki Yamakawa; Kazuhiko Nakao; Junji Irie
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

Review 4.  Endoscopic therapy in acute recurrent pancreatitis.

Authors:  John Baillie
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 5.  Endoscopic papillectomy: The limits of the indication, technique and results.

Authors:  José Celso Ardengh; Rafael Kemp; Éder Rios Lima-Filho; José Sebastião Dos Santos
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

6.  Therapeutic outcomes of endoscopic papillectomy for ampullary neoplasms: retrospective analysis of a multicenter study.

Authors:  Sung Hoon Kang; Kook Hyun Kim; Tae Nyeun Kim; Min Kyu Jung; Chang Min Cho; Kwang Bum Cho; Ji Min Han; Ho Gak Kim; Hyun Soo Kim
Journal:  BMC Gastroenterol       Date:  2017-05-30       Impact factor: 3.067

Review 7.  Methods and outcome of the endoscopic treatment of ampullary tumors.

Authors:  Jan-Werner Poley; Sara Campos
Journal:  Ther Adv Gastrointest Endosc       Date:  2020-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.